Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07637396 · ClinicalTrials.gov registry record
Ankle-Brachial Index Changes Post Exercise and Its Effects on Patient-Centered Outcomes and Gait
A clinical trial, sponsored by Louisiana State University Health Sciences Center Shreveport.
- Not yet
- Registry status
- 85
- Enrollment target
NCT07637396: Clinical Trial study, sponsored by Louisiana State University Health Sciences Center Shreveport.
NCT07637396 is a clinical trial that has not yet begun recruiting, run by Louisiana State University Health Sciences Center Shreveport. The registered enrollment target is 85 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07637396 has not yet begun recruiting, sponsored by Louisiana State University Health Sciences Center Shreveport.
- NOT YET RECRUITING
- Registry status
- 85 participants
- Enrollment target
Study Summary
The goal of this observational study or clinical trial is to investigate how exercise can affect different areas of a person's life, especially those people with vascular disease. This is important because exercise can be beneficial for people with vascular disease. The study could include any of the following: those aged 65 years of age and older, between the ages of 50-64 who smokes, has diabetes, high blood pressure, high cholesterol, or has a family member with vascular disease, between the ages of 18-49 with diabetes and one other factor listed above, or those with vascular disease. The main question\[s\] it aims to answer is if exercise testing can better predict vascular disease. The following research questions will be addressed in this study: 1. Does baseline ABI influence the magnitude and recovery trajectory of ABI following an acute bout of exercise across a spectrum of vascular function? 2. What association does exercise-induced ABI changes have on patient-reported outcomes of quality of life and intermittent claudication? 3. Do functional outcomes of gait speed, time to claudication, gait variables related to rest breaks in 6MWT, and walking distance predict the magnitude of exercise-induced ABI reduction? Participants will : * complete various questionnaires and a routine screening for vascular disease \*walk for 6 minutes at your own pace * additional vascular screening tests will be performed.
Primary Outcome
Measured as both absolute and percent change, calculated as the difference between baseline ABI and ABI immediately after exercise, at 1-, 3-, and 5-minute recovery intervals.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-01 |
What is known before NCT07637396 opens enrollment
NCT07637396 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 85 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT07637396 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07637396 about?
NCT07637396 is a clinical study titled "Ankle-Brachial Index Changes Post Exercise and Its Effects on Patient-Centered Outcomes and Gait". The goal of this observational study or clinical trial is to investigate how exercise can affect different areas of a person's life, especially those people with vascular disease. This is important because exercise can be beneficial for people with vascular disease. The study could include any of th...
What is the current status of trial NCT07637396?
This trial is currently not yet recruiting. The enrollment target is 85 participants. The study started on 2026-06. Estimated completion is 2028-01.
Who is sponsoring clinical trial NCT07637396?
This trial is sponsored by Louisiana State University Health Sciences Center Shreveport, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia